Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients

Biomarkers and immune-modulating therapies for Type 2 diabetes

(2012) Barbara Brooks-Worrell et al.   TRENDS IN IMMUNOLOGY

Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation

(2011) B. Brooks-Worrell et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients

(2010) B. M. Brooks-Worrell et al.   DIABETES CARE

Peroxisome Proliferator-Activated Receptor   and   Agonists Together with TGF-  Convert Human CD4+CD25- T Cells into Functional Foxp3+ Regulatory T Cells

(2010) J. Lei et al.   JOURNAL OF IMMUNOLOGY

Validity and Reproducibility of Measurement of Islet Autoreactivity by T-Cell Assays in Subjects With Early Type 1 Diabetes

(2009) K. C. Herold et al.   DIABETES

Islet-associated macrophages in type 2 diabetes

(2009) S. J. Richardson et al.   DIABETOLOGIA

Improved T cell assay for identification of type 1 diabetes patients

(2009) Barbara Brooks-Worrell et al.   JOURNAL OF IMMUNOLOGICAL METHODS

PPARγ regulates retinoic acid-mediated DC induction of Tregs

(2009) William J. Housley et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction

(2009) Jan A. Ehses et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

(2008) M. Y. Donath et al.   DIABETES CARE

PPAR-γ: Therapeutic Potential for Multiple Sclerosis

(2008) Paul D. Drew et al.   PPAR Research